These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9171883)
1. Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin. Franchetti P; Cappellacci L; Sheikha GA; Jayaram HN; Gurudutt VV; Sint T; Schneider BP; Jones WD; Goldstein BM; Perra G; De Montis A; Loi AG; La Colla P; Grifantini M J Med Chem; 1997 May; 40(11):1731-7. PubMed ID: 9171883 [TBL] [Abstract][Full Text] [Related]
2. Furanfurin and thiophenfurin: two novel tiazofurin analogues. Synthesis, structure, antitumor activity, and interactions with inosine monophosphate dehydrogenase. Franchetti P; Cappellacci L; Grifantini M; Barzi A; Nocentini G; Yang H; O'Connor A; Jayaram HN; Carrell C; Goldstein BM J Med Chem; 1995 Sep; 38(19):3829-37. PubMed ID: 7562914 [TBL] [Abstract][Full Text] [Related]
3. Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors. Franchetti P; Cappellacci L; Perlini P; Jayaram HN; Butler A; Schneider BP; Collart FR; Huberman E; Grifantini M J Med Chem; 1998 May; 41(10):1702-7. PubMed ID: 9572896 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, conformational analysis, and biological activity of C-thioribonucleosides related to tiazofurin. Franchetti P; Marchetti S; Cappellacci L; Jayaram HN; Yalowitz JA; Goldstein BM; Barascut JL; Dukhan D; Imbach JL; Grifantini M J Med Chem; 2000 Apr; 43(7):1264-70. PubMed ID: 10753464 [TBL] [Abstract][Full Text] [Related]
5. Comparison of biochemical parameters of benzamide riboside, a new inhibitor of IMP dehydrogenase, with tiazofurin and selenazofurin. Gharehbaghi K; Sreenath A; Hao Z; Paull KD; Szekeres T; Cooney DA; Krohn K; Jayaram HN Biochem Pharmacol; 1994 Oct; 48(7):1413-9. PubMed ID: 7945441 [TBL] [Abstract][Full Text] [Related]
6. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis. Jayaram HN; Cooney DA; Grusch M; Krupitza G Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601 [TBL] [Abstract][Full Text] [Related]
7. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture. Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005 [TBL] [Abstract][Full Text] [Related]
8. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents. Franchetti P; Grifantini M Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603 [TBL] [Abstract][Full Text] [Related]
9. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase. Sokoloski JA; Blair OC; Sartorelli AC Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796 [TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of action of benzamide riboside: a novel inhibitor of IMP dehydrogenase. Gharehbaghi K; Grünberger W; Jayaram HN Curr Med Chem; 2002 Apr; 9(7):743-8. PubMed ID: 11966437 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and antitumor activity of tiazofurin and its selenium analog (2-beta-D-ribofuranosyl-4-selenazolecarboxamide). Boritzki TJ; Berry DA; Besserer JA; Cook PD; Fry DW; Leopold WR; Jackson RC Biochem Pharmacol; 1985 Apr; 34(7):1109-14. PubMed ID: 3985993 [TBL] [Abstract][Full Text] [Related]
12. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives. Minakawa N; Matsuda A Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604 [TBL] [Abstract][Full Text] [Related]
13. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin. Robins RK; Revankar GR; McKernan PA; Murray BK; Kirsi JJ; North JA Adv Enzyme Regul; 1985; 24():29-43. PubMed ID: 2872781 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosides. Matsumoto SS; Fujitaki JM; Nord LD; Willis RC; Lee VM; Sharma BS; Sanghvi YS; Kini GD; Revankar GR; Robins RK Biochem Pharmacol; 1990 Feb; 39(3):455-62. PubMed ID: 1968339 [TBL] [Abstract][Full Text] [Related]
15. Tiazofurin and selenazofurin induce depression of cGMP and phosphatidylinositol pathway in L1210 leukemia cells. Parandoosh Z; Robins RK; Belei M; Rubalcava B Biochem Biophys Res Commun; 1989 Oct; 164(2):869-74. PubMed ID: 2554903 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides. Meade EA; Wotring LL; Drach JC; Townsend LB J Med Chem; 1997 Feb; 40(5):794-801. PubMed ID: 9057866 [TBL] [Abstract][Full Text] [Related]
17. Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). Lui MS; Faderan MA; Liepnieks JJ; Natsumeda Y; Olah E; Jayaram HN; Weber G J Biol Chem; 1984 Apr; 259(8):5078-82. PubMed ID: 6143752 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design. Colby TD; Vanderveen K; Strickler MD; Markham GD; Goldstein BM Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3531-6. PubMed ID: 10097070 [TBL] [Abstract][Full Text] [Related]
19. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity. Cooney DA; Jayaram HN; Glazer RI; Kelley JA; Marquez VE; Gebeyehu G; Van Cott AC; Zwelling LA; Johns DG Adv Enzyme Regul; 1983; 21():271-303. PubMed ID: 6152729 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antiproliferative activity of IPCAR, a new pyrazole nucleoside analog. Pani A; Marongiu ME; Pinna E; Scintu F; Perra G; Montis AD; Manfredini S; La Colla P Anticancer Res; 1998; 18(4A):2623-30. PubMed ID: 9703919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]